School of Medical Science and Technology

No Record Found.

Book
• Regenerative Medicine: Emerging Techniques to Translation Approaches Shukla P. C., Chakravorty N. By - (2023)
Journal
• Natural Killer T cells and the invariant subset promote atherosclerosis: A meta-analysis Chakrabarti R., Duddu S. , Tiwari A. , Naidu K. , Sharma P. , Chakravorty N. , Shukla P. C. By Life Sciences 321 121620- (2023)
• Large-scale microRNA functional high-throughput screening identifies miR-515-3p and miR-519e-3p as inducers of human cardiomyocyte proliferation Renikunta H. V., Lazarow K. , Gong Y. , Shukla P. C., Landmesser U. , Jakob P. , . .. By iScience 26 - (2023)
• Exploring the crosstalk between long non-coding RNAs and microRNAs to unravel potential prognostic and therapeutic biomarkers in -thalassemia Rahaman M., Mukherjee M. , Bhattacharya S. , Mukherjee B. , Shukla P. C., Dolai T. K., Chakravorty N. By Mol Biol Rep 49 7057-7068 (2022)
• Meta-analysis reveals inhibition of the inflammatory cytokine IL-6 affords limited protection post-myocardial ischemia/infarction Duddu S., Agrawal M. , Chakrabarti R. , Ghosh A. , Chakravorty N. , Tiwari A. , Shukla P. C. By Heliyon 8 1-15 (2022)
• Revisiting fetal hemoglobin inducers in beta-hemoglobinopathies: a review of natural products, conventional and combinatorial therapies Mukherjee M., Rahaman M., Ray S.K., Shukla P.C., Dolai T.K., Chakravorty N. By Molecular Biology Reports 49 2359-2373 (2022)
• Inadvertent nucleotide sequence alterations during mutagenesis: highlighting the vulnerabilities in mouse transgenic technology Ghosh A., Chakrabarti R. , Shukla P. C. By J Genet Eng Biotechnol 19 30-41 (2021)
• Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer Bhattacharya A., Chowdhury A., Chaudhury K., Shukla P.C. By Biochimica et biophysica acta. Reviews on cancer 1876 188581- (2021)
• Hematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology Duddu S., Chakrabarti R. , Ghosh A. , Shukla P. C. By Frontiers in Genetics 11 - (2020)
• The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis Loebel M., Luise Holzhauser L. , Hartwig J. A., Shukla P. C., Savvatis K. , Janke A. , Gast M. , Escher F. , Becker S. C., Bauer S. , Stroux A. , Beling A. , Kespohl M. , Pinkert S. , Fechner H. , Kuehl U. , Lassner D. , Poller W. , Schultheiss H. , Zeller T. , Blankenberg S. , Papageorgiou A. , Heymans S. , Landmesser U. , Scheibenbogen C. , Skurk C. By European Heart Journal 39 876-887 (2018)
• Glutathione adducts on sarcoplasmic/endoplasmic reticulum Ca2+ ATPase C674 regulate endothelial cell calcium stores and angiogenic function as well as promotes ischemic blood flow recovery Thompson, M.D., Mei, Y., Weisbrod, R.M., Silver, M., Shukla, P.C., Bolotina, V.M., Cohen, R.A., Tong, X. By Journal of Biological Chemistry 289 (29) - (2014)
• Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1 *Singh, K.K., *Shukla, P.C., *Yanagawa, B., Quan, A., Lovren, F, Pan, Y., Wagg, C. S., Teoh, H., Lopaschuk, G. D., Verma, S. By Journal of Thoracic and Cardiovascular Surgery 146 (3) - (2013)
• BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis. Teoh H., Quan A. , Creighton A. K., Annie Bang K. W., Shukla P. C., Verma S. By Gene Therapy 20 51-61 (2013)
• BRCA1 is a Novel Target to Improve Endothelial Dysfunction and Retard Atherosclerosis *Singh, K.K., *Shukla, P.C., Quan, A., Al-Omran, M., Lovren, F., Pan, Y., Brezden-Masley, C., Ingram, A.J., Stanford, W.L., Teoh, H., Verma, S. By Journal of Thoracic and Cardiovascular Surgery 146 (4) - (2013)
• MicroRNA-145 targeted therapy reduces atherosclerosis Lovren F., Pan Y. , Quan A. , Singh K. K., Shukla P. C., Gupta N. , Steer B. M., Ingram A. J., Verma S. By Circulation 126 81-90 (2012)
• miRNA-141 is a novel regulator of BMP-2-mediated calcification in aortic stenosis Yanagawa B., Lovren F. , Pan Y. , Garg V. , Quan A. , Tang G. , Shukla P. C., Verma S. By J Thorac Cardiovasc Surg. 144 256-262 (2012)
• BRCA2 deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure *Singh, K.K., *Shukla, P.C., Quan, A., Desjardins, J-F., Lovren, F., Pan, Y., Garg, V., Gosal, S., Garg, A., Szmitko, P.E., Schneider, M.D., et. al. By Journal of Biological Chemistry 287 (9) - (2012)
• Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces p53-mediated cardiomyocyte death Singh* K. K., Shukla* P. C., .. By Biochem Biophys Res Commun. 411 421-426 (2011)
• BRCA1 is an essential regulator of heart function and survival following myocardial infarction Shukla, P.C*., Singh, K.K*., Quan, A., Al-Omran, M. et. al. By Nature Communication 2 - (2011)
• Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction Hilfiker-Kleiner, D., Shukla, P.C., Klein, G., Fischer, P., Schaefer, A., Stapel, B., Hoch, M., Müller, W., Scherr, M.,Theilmeier, G., Ernst, M., Hilfiker, A., Drexler, H. By Circulation 122 (2) - (2010)
• Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKC epsilon Klein, G., Schaefer, A., Hilfiker-Kleiner, D., Oppermann, D., Shukla, P.C., Quint, A., Podewski, E., Hilfiker, A., Schroder, F., Leitges, M., Drexler, H. By Circulation Research 15;96 (7) - (2005)

Principal Investigator

• Identification of Non-coding RNAs Regulation MLKL/RIPK3 Pathway in Vascular Smooth Muscle Cells: Role of Novel Non-coding RNAs in VSMC Necroptosis

Co-Principal Investigator

• MHC Haplotypes in HBE/Beta Thalassemia: Correlating Disease Heterogeneity and Blood Transfusion Requirements in West Bengal